Skip to search formSkip to main contentSkip to account menu

enzalutamide Oral Capsule [Xtandi]

National Institutes of Health

Related topics

Related topics

3 relations
Oral CapsuleXtandi

Narrower (1)

enzalutamide 40 MG Oral Capsule [Xtandi]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Cross-Resistance Among Next-Generation Antiandrogen Drugs Through the AKR1C3/AR-V7 Axis in Advanced Prostate Cancer
The next-generation antiandrogen drugs, XTANDI (enzalutamide), ZYTIGA (abiraterone acetate), ERLEADA (apalutamide) and NUBEQA… 
2019
2019
Enzalutamide (Xtandi®) in addition to standard first-line therapy in men with metastatic hormone-sensitive prostate cancer (mHSPC)
Patients with metastatic hormone-sensitive prostate cancer (mHSPC) have never received androgen deprivation therapy (ADT) before… 
2012
2012
The promise of dual targeting Akt/mTOR signaling in lethal prostate cancer
According to the American Cancer Society approximately 242,000 new cases of prostate cancer will be reported in 2012, making it… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)